Repository logo
 
Publication

Radiolabeled polyethyleneiminomethyl phosphonic acid as a molecule with potential for diagnosis and therapy. Comparative study on models of bladder cancer and osteossarcoma.

dc.contributor.authorFerreira, Sara
dc.contributor.authorAbrantes, Ana Margarida
dc.contributor.authorBrito, Ana
dc.contributor.authorLaranjo, Mafalda
dc.contributor.authorMetello, Luís F.
dc.contributor.authorZeevart, Jan
dc.contributor.authorLouw, Werner
dc.contributor.authorDormehl, Irene
dc.contributor.authorBotelho, Maria Filomena
dc.date.accessioned2015-07-09T16:03:14Z
dc.date.available2015-07-09T16:03:14Z
dc.date.issued2013
dc.description.abstractIntroduction: The polymer PEI-MP (polyethyleneiminomethyl phosphonic acid) that might be labeled with 99mTc and 188Re, have a strong potential for diagnosis and metabolic radiotherapy, respectively. The aim of this study was to evaluate the efficacy of 99mTc-PEI-MP for diagnosis and 188Re-PEI-MP as therapeutic agent, in a comparative study using in vitro and in vivo models of bladder cancer and osteossarcomaeng
dc.identifier.urihttp://hdl.handle.net/10400.22/6458
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherSpringerpor
dc.titleRadiolabeled polyethyleneiminomethyl phosphonic acid as a molecule with potential for diagnosis and therapy. Comparative study on models of bladder cancer and osteossarcoma.por
dc.typeother
dspace.entity.typePublication
oaire.citation.endPageS454por
oaire.citation.startPageS454por
oaire.citation.titleEuropean Journal of Nuclear Medicine and Molecular Imaging - 26th Annual Congress of the European Association of Nuclear Medicinepor
oaire.citation.volume40por
rcaap.rightsopenAccesspor
rcaap.typeotherpor

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
EANM_2013.pdf
Size:
231.72 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: